MYL3/CMLC1 antibody (C-Term) (Biotin)
Quick Overview for MYL3/CMLC1 antibody (C-Term) (Biotin) (ABIN8012842)
Target
See all MYL3/CMLC1 (MYL3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- Anti-MYL3 Antibody Biotin Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human MYL3, which shares 91.3% amino acid (aa) sequence identity with both mouse and rat MYL3.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))
-
Alternative Name
- MYL3
-
Background
-
Background: Myosin essential light chain (ELC), ventricular/cardiac isoform is a protein that in humans is encoded by the MYL3 gene. MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
Gene Full Name: myosin light chain 3
-
Gene ID
- 4634
-
UniProt
- P08590
Target
-